Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Viemed Healthcare stock
Own Viemed Healthcare stock in just a few minutes.
Viemed Healthcare, Inc is a medical devices business based in the US. Viemed Healthcare shares (VMD) are listed on the NASDAQ and all prices are listed in US Dollars. Viemed Healthcare employs 499 staff and has a trailing 12-month revenue of around USD$121.6 million.
How to buy shares in Viemed Healthcare
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Viemed Healthcare. Find the stock by name or ticker symbol: VMD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Viemed Healthcare reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Viemed Healthcare, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Viemed Healthcare. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Viemed Healthcare share price
Use our graph to track the performance of VMD stocks over time.Viemed Healthcare shares at a glance
Information last updated 2021-03-03.
| 52-week range | USD$2.44 - USD$11.93 |
|---|---|
| 50-day moving average | USD$9.4743 |
| 200-day moving average | USD$9.1718 |
| Wall St. target price | N/A |
| PE ratio | 38.8 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$0.25 |
Buy Viemed Healthcare shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Viemed Healthcare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Viemed Healthcare under- or over-valued?
Valuing Viemed Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Viemed Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Viemed Healthcare's P/E ratio
Viemed Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Viemed Healthcare shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Viemed Healthcare's EBITDA
Viemed Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$26.9 million.
The EBITDA is a measure of a Viemed Healthcare's overall financial performance and is widely used to measure a its profitability.
Viemed Healthcare financials
| Revenue TTM | USD$121.6 million |
|---|---|
| Operating margin TTM | 14.92% |
| Gross profit TTM | USD$56 million |
| Return on assets TTM | 11.69% |
| Return on equity TTM | 48.57% |
| Profit margin | 23.73% |
| Book value | $1.148 |
| Market capitalisation | USD$379 million |
TTM: trailing 12 months
Shorting Viemed Healthcare shares
There are currently 1.3 million Viemed Healthcare shares held short by investors – that's known as Viemed Healthcare's "short interest". This figure is 1.2% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting Viemed Healthcare shares can be evaluated.
Viemed Healthcare's "short interest ratio" (SIR)
Viemed Healthcare's "short interest ratio" (SIR) is the quantity of Viemed Healthcare shares currently shorted divided by the average quantity of Viemed Healthcare shares traded daily (recently around 193377.8280543). Viemed Healthcare's SIR currently stands at 6.63. In other words for every 100,000 Viemed Healthcare shares traded daily on the market, roughly 6630 shares are currently held short.
However Viemed Healthcare's short interest can also be evaluated against the total number of Viemed Healthcare shares, or, against the total number of tradable Viemed Healthcare shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Viemed Healthcare's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Viemed Healthcare shares in existence, roughly 30 shares are currently held short) or 0.0365% of the tradable shares (for every 100,000 tradable Viemed Healthcare shares, roughly 37 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Viemed Healthcare.
Find out more about how you can short Viemed Healthcare stock.
Viemed Healthcare share dividends
We're not expecting Viemed Healthcare to pay a dividend over the next 12 months.
Viemed Healthcare share price volatility
Over the last 12 months, Viemed Healthcare's shares have ranged in value from as little as $2.44 up to $11.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Viemed Healthcare's is 0.7622. This would suggest that Viemed Healthcare's shares are less volatile than average (for this exchange).
Viemed Healthcare overview
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
Frequently asked questions
More guides on Finder
-
How to buy Achilles Therapeutics plc (ACHL) stock when it goes public
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
-
How to buy SEMrush Holdings Inc (SEMR) stock when it goes public
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
-
How to buy ChargePoint (VMD.US) stock when it goes public
Everything we know about the ChargePoint IPO, plus information on how to buy in.
-
How to buy Kaltura Inc (KLTR) stock when it goes public
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
-
How to buy Rocket Lab (VMD.US) stock when it goes public
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
-
How to buy Soho House (VMD.US) stock when it goes public
Everything we know about the Soho House IPO, plus information on how to buy in.
-
How to buy VIZIO (VZIO) stock when it goes public
Everything we know about the VIZIO IPO, plus information on how to buy in.
-
How to buy IDW Media Holdings Inc (IDW) stock when it goes public
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
-
How to buy Karooooo Ltd (KARO) stock when it goes public
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
-
How to buy Connect Biopharma Holdings Limited (CNTB) stock when it goes public
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
Ask an Expert